Barchart on MSN1d
Insulet Stock Outlook: Is Wall Street Bullish or Bearish?
Insulet Corporation (PODD), headquartered in Acton, Massachusetts, operates as an innovative medical device company. Valued ...
Insulet Sales Keep Rising
Insulet Corporation (PODD) continues its strong sales and growth trend.
StockNews.com Upgrades Insulet (NASDAQ:PODD) to “Buy”
Insulet (NASDAQ:PODD – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research ...
Insulet Corp. stock underperforms Tuesday when compared to competitors
Insulet Corp. closed 7.87% below its 52-week high of $289.46, which the company achieved on February 7th.
Hosted on MSN5d
Insulet’s (NASDAQ:PODD) Q4: Beats On Revenue, Quarterly Revenue Guidance Slightly Exceeds Expectations
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2024 results , with sales up 17.2% year on year to ...
Q1 Earnings Forecast for Insulet Issued By Leerink Partnrs
Stock analysts at Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for Insulet in a research note ...
Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst
Insulet Corporation (NASDAQ:PODD) reported fourth-quarter adjusted EPS of $1.15, down from $1.40 a year ago but beating the ...
Insulet: Aiding Patients And Investors
Insulet's impressive growth with its Omnipod system, robust 2024 results, and surging valuation make it attractive. See more ...
Insulet (PODD) Receives a Hold from Stifel Nicolaus
Stifel Nicolaus analyst Mathew Blackman maintained a Hold rating on Insulet (PODD – Research Report) today and set a price target of $293.00.
Yahoo Finance6d
Insulet (PODD) Q4 Earnings and Revenues Top Estimates
Insulet (PODD) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.40 per share a year ago. These figures ...